10/29/2015 - 12:12pm

The company would not comment on th

10/29/2015 - 10:35am

McKesson's North America pharmaceutical distribution and services revenues were $40.6 billion for the quarter, up 16% on a reported basis and 17% on a constant currency basis. 

10/28/2015 - 2:15pm

HealthDay is reporting that researchers fromt the University of Michigan’s Survey Research Center have found that a person’s use of narcotic painkillers as a teen raises their risk of abuse as an adult by 33%. “Most likely, the initial experience of pain relief is pleasurable and a safe initial experience may reduce perceived danger,” the study’s author Richard Miech said. “A pleasurable and safe initial experience with a drug is a central factor in theories of who goes on to misuse drugs.” (HealthDay)

10/28/2015 - 11:26am

Some 77% of those polled by the Kaiser Family Foundation in October said that ensuring the affordability of high-cost drugs for patients with chronic conditions should be the government’s top health care priority. 

10/27/2015 - 3:38pm

The company has received the FDA’s OK for its generic of Ultram, which is indicated to treat moderate to moderately severe chronic pain. 

10/27/2015 - 3:29pm

Davis said that rather than support the budget deal’s Medicaid provisions, lawmakers should work to pass the Fair Access to Safe and Timely Generics Act, a bill that has been introduced by Reps. Steve Stivers, R-Ohio, and Peter Welch, D-Vt. 

10/27/2015 - 11:44am

The drug is intended for rescue use following treatment of osteosarcoma through methotrexate therapy by reducing toxicity and effect of eliminating methotrexate.

10/27/2015 - 10:05am

The authors say this is the first study to show that a pharmacist-based glucose control program can potentially improve outcomes for surgery patients, and also lead to lower costs. 

10/23/2015 - 10:31am

Aurobindo Pharma announced Thursday that it had received approval for its generic Namenda (memantine HCL) tablets.